BioSpace News Archive

Aptose Biosciences Inc. announced financial results for the three months ended September 30, 2019 and reported on corporate developments.

Conatus Pharmaceuticals Inc. announced financial results for the quarter and nine months ended September 30, 2019..

GW Pharmaceuticals plc announces financial results for the third quarter ended September 30, 2019.

Synthorx, Inc. reported financial results and provided a business update for the third quarter ended September 30, 2019.

CV Sciences, Inc., a preeminent supplier and manufacturer of hemp cannabidiol products, announced its financial results for the quarter ended September 30, 2019.

Codexis, Inc., a leading protein engineering company, announces financial results for the three and nine months ended September 30, 2019 and provides a business update.

Third quarter revenue decreased 8.5 percent to $26.5 million; year-to-date revenue increased 5 percent to $84.8 million

OPKO Health, Inc. reports business highlights and financial results for the three months ended September 30, 2019..

Palladio Biosciences, Inc. (Palladio), announced today that preliminary results of the ELiSA Phase 2 study of lixivaptan for the treatment of Autosomal Polycystic Kidney Disease (ADPKD) and the clinical design and main elements of the Phase 3 registrational program for lixivaptan in patients with ADPKD will be presented in two poster sessions during the American Society of Nephrology’s Kidney Week 2019,

The Integrated Healthcare Association named MemorialCare Medical Group and Greater Newport Physicians winners of its Excellence in Healthcare Award, California’s top honor for physician organizations.